Evidence map›Paper›PMID 29721634›Full record

SynthesisDiabetologia2018

Discordant association of the CREBRF rs373863828 A allele with increased BMI and protection from type 2 diabetes in Māori and Pacific (Polynesian) people living in Aotearoa/New Zealand.

Mohanraj Krishnan, Tanya J Major, Ruth K Topless, Ofa Dewes, Lennex Yu, John M D Thompson, Lesley McCowan, Janak de Zoysa, Lisa K Stamp, Nicola Dalbeth and 16 more

Open access · bronzeAbstract readMeta-Analysis
In one paragraph

Synthesis in Diabetologia, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 2 pooled it
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 2 syntheses or guidelines pooled it, 83 citations in OpenAlex.

  1. Pooled it
  2. A stop-gain variant inHGG advances · 2023
    Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Phenotypic and Genetic Diversity in Diabetes Across Populations.The Journal of clinical endocrinology and metabolism · 2025
    Review
  13. Article
  14. Article
  15. Article
  16. Reduced Weight Gain with Pioglitazone vs Vildagliptin inDiabetes, metabolic syndrome and obesity : targets and therapy · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 8 institutions in 3 countries.

Mohanraj KrishnanDepartment of Obstetrics and Gynaecology, University of Auckland, Auckland, New Zealand.
Tanya J MajorDepartment of Biochemistry, University of Otago, 710 Cumberland Street, Dunedin, 9054, New Zealand.
Ruth K ToplessDepartment of Biochemistry, University of Otago, 710 Cumberland Street, Dunedin, 9054, New Zealand.
Ofa DewesMaurice Wilkins Centre for Molecular Biodiscovery, Auckland, New Zealand.
Lennex YuDepartment of Anatomy and Medical Imaging, University of Auckland, Auckland, New Zealand.
John M D ThompsonDepartment of Obstetrics and Gynaecology, University of Auckland, Auckland, New Zealand.
Lesley McCowanDepartment of Obstetrics and Gynaecology, University of Auckland, Auckland, New Zealand.
Janak de ZoysaRenal Services, Waitemata District Health Board, Auckland, New Zealand.
Lisa K StampDepartment of Medicine, University of Otago Christchurch, Christchurch, New Zealand.
Nicola DalbethDepartment of Medicine, Faculty of Medical and Health Sciences, University of Auckland University of Auckland, Auckland, New Zealand.
Jennie Harré HindmarshNgāti Porou Hauora Charitable Trust, Te Puia Springs, Tairāwhiti East Coast, New Zealand.
Nuku RapanaPukapuka Community of New Zealand Inc., Mangere, Auckland, New Zealand.
Ranjan DekaDepartment of Environmental Health, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
Winston W H EngDepartment of Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA.
Daniel E WeeksDepartment of Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA.
Ryan L MinsterDepartment of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA.
Stephen T McGarveyInternational Health Institute, Department of Epidemiology, Brown University School of Public Health, and Department of Anthropology, Brown University, Providence, RI, USA.
Satupa'itea VialiSamoa National Health Service, Apia, Samoa.
Take NaseriMinistry of Health, Government of Samoa, Apia, Samoa.
Muagututi'a Sefuiva ReupenaBureau of Statistics, Government of Samoa, Apia, Samoa.
Phillip WilcoxDepartment of Mathematics and Statistics, University of Otago, Dunedin, New Zealand.
David GrattanMaurice Wilkins Centre for Molecular Biodiscovery, Auckland, New Zealand.
Peter R ShepherdDepartment of Medicine, Faculty of Medical and Health Sciences, University of Auckland University of Auckland, Auckland, New Zealand.
Andrew N ShellingDepartment of Obstetrics and Gynaecology, University of Auckland, Auckland, New Zealand.
Rinki MurphyDepartment of Medicine, Faculty of Medical and Health Sciences, University of Auckland University of Auckland, Auckland, New Zealand.
Tony R MerrimanDepartment of Biochemistry, University of Otago, 710 Cumberland Street, Dunedin, 9054, New Zealand. tony.merriman@otago.ac.nz.
University of Auckland · NZMaurice Wilkins Centre · NZUniversity of Otago · NZNational University of Samoa · WSUniversity of Pittsburgh · USBrown University · USUniversity of Cincinnati Medical Center · USWaitemata District Health Board · NZ

Funding

Integrated cellular, mouse and human research on a novel missense variant influencing adiposity in SamoansR01HL093093 · NHLBI · BROWN UNIVERSITY · PI MCGARVEY, STEPHEN T. · 2009 to 2019
$8.2M
Next Generation Association Studies of Adiposity in Samoans Enhanced by a Samoan-Specific Whole Genome Sequence Reference PanelR01HL133040 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Ryan Lee Minster · 2017 to 2026
$7.5M
Health Research Council of New Zealand 08/075Health Research Council of New Zealand 10/548Health Research Council of New Zealand 11/1075Health Research Council of New Zealand 14/527National Institute of Health R01-HL093093National Institute of Health R01-HL133040NHLBI NIH HHS R01 HL093093NHLBI NIH HHS R01 HL133040
6 · The paper itself

Abstract

aims/hypothesisThe A (minor) allele of CREBRF rs373863828 has been associated with increased BMI and reduced risk of type 2 diabetes in the Samoan populations of Samoa and American Samoa. Our aim was to test rs373863828 for associations with BMI and the odds of type 2 diabetes, gout and chronic kidney disease (CKD) in Māori and Pacific (Polynesian) people living in Aotearoa/New Zealand.

methodsLinear and logistic regression models were used to analyse the association of the A allele of CREBRF rs373863828 with BMI, log-transformed BMI, waist circumference, type 2 diabetes, gout and CKD in 2286 adults. The primary analyses were adjusted for age, sex, the first four genome-wide principal components and (where appropriate) BMI, waist circumference and type 2 diabetes. The primary analysis was conducted in ancestrally defined groups and association effects were combined using meta-analysis.

resultsFor the A allele of rs373863828, the effect size was 0.038 (95% CI 0.022, 0.055, p = 4.8 × 10 CONCLUSIONS/

interpretationOur results in New Zealand Polynesian adults replicate, with very similar effect sizes, the association of the A allele of rs373863828 with higher BMI but lower odds of type 2 diabetes among Samoan adults living in Samoa and American Samoa.

Indexed as

Body Mass IndexDiabetes Mellitus, Type 2ObesityPolymorphism, Single NucleotideTumor Suppressor ProteinsAdultAgedFemaleGene FrequencyGenetic Association StudiesGenetic Predisposition to DiseaseHumansMaleMaori PeopleMiddle AgedNew ZealandCREB3 regulatory factor, humanTumor Suppressor ProteinsAssociationBMICREBRFGeneticMāoriObesityPacificPolynesianType 2 diabetes

Identifiers

PMID29721634
PMCPMC6434933
OpenAlexW2952130055

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.